8VAO
Simulation-driven design of prefusion stabilized SARS-CoV-2 spike S2 antigen
Entity
Entity ID | Chain ID | Description | Type | Chain length | Formula weight | Number of molecules | DB Name (Accession) | Biological source | Descriptive keywords |
1 | A, B, C | Spike protein S2 | polymer | 512 | 56323.5 | 3 | UniProt (P0DTC2) In PDB | Severe acute respiratory syndrome coronavirus 2 | |
2 | A, B, C | 2-acetamido-2-deoxy-beta-D-glucopyranose | non-polymer | 221.2 | 9 | Chemie (NAG) |
Sequence modifications
A, B, C: 697 - 1208 (UniProt: P0DTC2)
PDB | External Database | Details |
---|---|---|
Cys 704 | Ser 704 | engineered mutation |
Cys 790 | Lys 790 | engineered mutation |
Pro 817 | Phe 817 | engineered mutation |
Pro 892 | Ala 892 | engineered mutation |
Pro 899 | Ala 899 | engineered mutation |
Pro 942 | Ala 942 | engineered mutation |
Glu 957 | Gln 957 | engineered mutation |
Pro 986 | Lys 986 | engineered mutation |
Pro 987 | Val 987 | engineered mutation |
Trp 991 | Val 991 | engineered mutation |
Trp 998 | Thr 998 | engineered mutation |
Sequence viewer
Contents of the asymmetric unit
Polymers | Number of chains | 3 |
Total formula weight | 168970.5 | |
Non-Polymers* | Number of molecules | 9 |
Total formula weight | 1990.9 | |
All* | Total formula weight | 170961.3 |